RepliCel Life Sciences (TSXV:RP) Shares Buyback Ratio % : -52.05 (As of Apr. 28, 2025)

View and export this data going back to 2012. Start your Free Trial

What is RepliCel Life Sciences Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. RepliCel Life Sciences's current shares buyback ratio was -52.05%.

RepliCel Life Sciences Shares Buyback Ratio % Historical Data

The historical data trend for RepliCel Life Sciences's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RepliCel Life Sciences Shares Buyback Ratio % Chart

RepliCel Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Shares Buyback Ratio %

Get a 7-Day Free Trial

-24.99

-5.55

-18.51

-4.28

-36.15

RepliCel Life Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-11.34	-36.57	-	-

RepliCel Life Sciences Shares Buyback Ratio % Calculation

RepliCel Life Sciences's Shares Buyback Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2021 )	-	Shares Outstanding (EOP) (A: Dec. 2022 ))	/	Shares Outstanding (EOP) (A: Dec. 2021 )
	=	(34.959	-	47.597)	/	34.959
	=	-36.15%

RepliCel Life Sciences's Shares Buyback Ratio for the quarter that ended in Sep. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2023 )	-	Shares Outstanding (EOP) (A: Sep. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	(65.002	-	65.002)	/	65.002
	=	0.00%

RepliCel Life Sciences Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of RepliCel Life Sciences's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

RepliCel Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RepliCel Life Sciences Inc (TSXV:RP) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

570 Granville Street, Suite 900, Vancouver, BC, CAN, V6C 3P1

Website

https://www.replicel.com

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles. Also, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company use autologous cell therapy which is developed for the treatment of androgenetic alopecia. The revenue is generated from the Licensing fees.

Executives